🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 69366J200
- Market Cap
- Large Cap · $1 Billion
- IPO
- 6/20/2013 · $15.00/share
Business: PTC Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. While its discovery programs are directed at targets in multiple therapeutic areas, the Company is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders.
Company Contact
- CEO
- Stuart W. Peltz, Ph.D.
- CFO
- Christine Utter
- Headquarters
- 100 Corporate Court, South Plainfield, NJ 07080
- Phone
- 908-222-7000
- Investor Relations
- Emily Hill · 908-912-9321 · ehill@ptcbio.com